chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Hospitalized (02.28.2022-03.02.2022); COVID-19 positive (02.28.2022); fully vaccinated plus booster  BRIEF OVERVIEW:  Admission Date: 2/28/2022 Discharge Date: 03/02/2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypokalemia Hypomagnesemia  Sigmoid diverticulitis  Acute kidney injury superimposed on chronic kidney disease  COVID-19 virus infection     HOSPITAL COURSE: Patient is an 86-year-old male initially presenting to the emergency department with chief complaint decreased oral intake and progressive weakness.  Patient also reported abdominal pain with associated diarrhea ongoing for the last 4-5 weeks. Chest x-ray with no evidence pneumonia.  CT of abdomen and pelvis with evidence of acute sigmoid diverticulitis and urethral thickening of the left renal pelvis with associated inflammatory changes in the left peripelvic and perirenal fat.  The patient was hemodynamically stable but did require 1 L of oxygen for oxygen saturation down to 88% on room air.  Admission labs with evidence of acute kidney injury with BUN of 46, creatinine of 2.45, magnesium of 1.1, WBC count of 6.8, hemoglobin 8.3.  Urinalysis with no evidence of nitrites or leukocytes with minimal wbc's.  Patient was admitted to the medical floor for further management.  Patient was initially started on Decadron, treated with IV fluids, Rocephin and Flagyl for mild diverticulitis and possible pyelitis.  Lasix and potassium was discontinued for AKI and volume depletion.  Patient improved with above measures.  Patient did have a recent admission for left frontal subdural hematoma/subarachnoid hemorrhage for which aspirin was discontinued.  Patient also had a recent admission for GI bleed and it was felt that patient did not need Decadron given no respiratory symptoms on day 2. On the day of discharge, patient was hemodynamically stable, tolerating a general diet, abdominal pain significantly improved.  Patient was not on any oxygen.  Patient reported that he was no longer taking Zoloft or BuSpar upon admission which will have to be addressed with PCP upon hospital follow-up.  Lasix and potassium was held upon discharge would swell need to be reviewed and possibly resumed upon next follow-up appointment with PCP.   Patient is being discharged in stable condition and was agreeable with discharge plans.
throw up again; throw up; A spontaneous report was received from a consumer concerning a 76-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events throw up, throw up again.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 17 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 039K20A) via unknown route for prophylaxis of COVID-19 infection.  On 19 Feb 2021, the patient experienced the event(s) throw up. On 2 Mar 2021, the patient experienced the event(s) throw up again.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), throw up, throw up again was unknown.
Approximately 12 hours after vaccine administration, I developed a headache and fatigue. Shortly after, I began to have joint pain and badly aches. Throughout the night, I would wake up frequently suffering from body aches and cold chills. Symptoms lasted for about 15 hours from time of onset.
Intermittent bone pain; Feeling very warm; Left lymph node pain; Headache; Sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 31Mar2021 00:30 (Lot number: EL 6955) at the age of 39 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: ALAVERT; IRON; MAGNESIUM; VITAMIN B [VITAMIN B NOS]. Vaccination history included: Bnt162b2 (administration time 09:30 AM, vaccine location Left arm, dose number 1, lot number EL 247), administration date: 10Mar2021, when the patient was 39 years old, for COVID-19 Immunization. The following information was reported: BONE PAIN (non-serious) with onset 01Apr2021 06:00, outcome "not recovered", described as "Intermittent bone pain"; FEELING HOT (non-serious) with onset 01Apr2021 06:00, outcome "not recovered", described as "Feeling very warm"; LYMPH NODE PAIN (non-serious) with onset 01Apr2021 06:00, outcome "not recovered", described as "Left lymph node pain"; HEADACHE (non-serious) with onset 01Apr2021 06:00, outcome "not recovered", described as "Headache"; PAIN IN EXTREMITY (non-serious) with onset 01Apr2021 06:00, outcome "not recovered", described as "Sore arm". Therapeutic measures were not taken as a result of bone pain, feeling hot, lymph node pain, headache, pain in extremity.  No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. On 20-OCT-2014 the patient was vaccinated with an expired dose of M-M-R II, dose 0.5 ml, subcutaneous, (lot # H015829 and expiration date 24-AUG-2014). No adverse effects was reported. Additional information has been requested.
This spontaneous report was received from a nurse regarding multiple unspecified patients of unknown age and gender. The patients' pertinent medical history, drug reactions or allergies and concomitant therapies were not reported. On unknown dates, the patients were vaccinated with an improperly stored doses of PROQUAD (Merck) (dose and route were not reported, lot # L030586, expiry date: 10-FEB-2017). There was no adverse effects reported. Lot number L030586 has been verified to be a valid lot number for PROQUAD (Merck). Albumin status was verified to be rHA. Follow up information was received on 12-FEB-2016 from a healthcare worker regarding a 4 year old male patient. On 27-JAN-2016, the patient was vaccinated with a dose of PROQUAD (Merck). This is one of the several reports from the same source. Additional information has been requested. Patient tab, product tab, event tab and narrative were updated.
10/8/13 - cold/cough symptoms. Urine - orangish color. Albuterol neb. 10/9/13 - brachycardia -> full arrest.
Starting 01/01/2022, I developed a scratchy throat, nasal drip and a slight cough. It was all contained within my sinuses. I had a lot of brain fog and felt extremely exhausted for 2 weeks. I had a mild fever but it was never high (101 was the highest it ever got). I tested positive with an at-home COVID-19 test on 01/03/2022. I contacted my doctor and they told me to alert the health department and to take whatever over the counter medications I would normally take for a cold to relieve symptoms. If it led to breathing issues/coughing, I was told to contact the office again, but that didn't happen. Due to my pre-existing asthma, my normal pulse oximeter would show 93% and during this event it varied between 87 -93%. It took about a month before my energy returned to normal. I started losing my hair in early march and I saw my doctor on 06/27/2022 who did a thyroid test to confirm it wasn't my thyroid. The test came back normal and the doctor told me it was likely due to stress from having COVID-19.
Body aches, chills, and head ache for approximately 48 hours. Took ibuprofen to help reduce symptoms.
This spontaneous report was received from a nurse refers to a patient of unknown age and gender. Medical history was not reported. The nurse informed that on 04-APR-2014 the patient was vaccinated with M-M-R II (strength, dosage and route were not reported) lot number: J007930, expiration date: 28-JUN-2015. That may had been improperly stored since February 2014. The thermometer battery ran out in February 2014, so the refrigerator temperature was not able to be confirmed to be within recommended storage temperature since then. The highest temperature the M-M-R II could had been exposed was 70F. Also stated that was no way to determine what the exact temperature was at any given time after 01-FEB-2014 since the battery in the thermometer stopped working. No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
8 YEARS OLD RECEIVED ADULT DOSE OF PFIZER COVID VACCINATION. IT WAS HIS SECOND DOSE . NO ADVERSE REACTION WAS REPORTED FROM MOM
pain, muscle spasm started on left side where vaccine was administered then spreaded to top of hip, started on 10.6.2020 and patient still feel almost the same on 10.19.2020 patient has appointment with doctor
I tested positive for COVID-19 on 10/13/22. I was sneezing, had drainage, chills, low grade fever, aching shoulders, and itching eyes. Any drainage that occurs with me, due to my Asthma, my Bronchial system reacted. I contacted my doctor and was prescribed Prednisone. I also took over-the-counter Sudafed with Guaifenesin. I was also drinking herbal teas. My drainage lasted for about 2 weeks.
pain and swelling at injection site progressed to pain down arm below elbow to fingertips along with numbness, severe shooting pain when arm was lifted, intense pain noted at 0400 on 12/30/2020 MD seen at 0800 on 12/30/2020 with swelling noted in arm - was instructed to alternate Tylenol/Ibuprofen around the clock x48 hours, instructed to use arm as much as possible throughout the day.   Pain was not as intense as it was at 0400 later in the morning/when MD was seen
Rash with hives, generalized burning sensation in skin, tachycardia with heart palpitations (4 days); Muscle weakness in all 4 extremities with pain, headache, irritability, fatigue, difficulty concentrating-(5+ days-continues).
Dizziness, Headache, Myalgia, Arthralgia, Fever, NauseaVomiting, CHILLS,EXTREME FATIGUE Narrative:  Other Relevant History:
pt stated that he had a very stiff left arm the next day after taking the vax.  About a week later his right arm became very stiff and painful that lasted about 3 days. he was concerned since it was not the arm where he got his vax.  Pt states he has very little pain now.
his blood sugar went up to 340; diarrhea; This is a spontaneous report based on the information received by Pfizer (Manufacturer Control No.: 01865903). A non-contactable consumer (patient) reported that a male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date: unknown) via an unspecified route of administration, on 05Feb2021, at a single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient applied for patient assistance for JANUVIA and found out from the agent that he did not qualify for assistance. In this call, the patient reported that he received the COVID-19 vaccine on Friday 05Feb2021. On 06Feb2021, Saturday, his blood sugar went up to 340 when it was usually in the 100's. To treat his elevated blood sugars, his doctor "doubled" his dose of metformin. Doubling his dose of metformin caused him to have diarrhea on an unspecified date in 2021. No additional adverse event or product quality complaint reported. Outcome of the events was unknown.  No follow-up attempts are possible; Information about batch/lot number cannot be obtained. No further information is expected.
Swelling of entire arm from armpit to fingertips.  Returned to doctor due to extreme reaction.  They verified that it was a vaccine reaction.  Arm stayed swelled for two weeks.  No further treatment.
As soon as vaccine was administered patient started to feel a taste of "metal and medicine". Soon after she started to have difficulty swallowing. These symptoms got worse slowly and 2 hrs later she reported them to the nurse. She went to the ER at 11:30 and was told her throat was swollen. She was given meds to help.
4 patients were administered vaccines from a vial that has been punctured for greater than 12hours; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (4 patients were administered vaccines from a vial that has been punctured for greater than 12hours) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (4 patients were administered vaccines from a vial that has been punctured for greater than 12hours). On 03-Nov-2021, EXPIRED PRODUCT ADMINISTERED (4 patients were administered vaccines from a vial that has been punctured for greater than 12hours) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant drugs are not provided. Treatment medications are not provided.
Information has been received from a physician concerning a 20 year old female who on 21-MAR-2008 was vaccinated intramuscularly "probably in the left arm" with her second dose of GARDASIL. On 24-MAR-2008 the patient called the doctor's office complaining of bruises and lump at the injection site and pain from her shoulder to armpit. The patient's bruises and lump at the injection site and pain from shoulder to armpit persisted. The patient did not experience any adverse effects after the first dose of GARDASIL. Additional information has been requested. 07/08/08 This is in follow-up to report(s) previously submitted on 4/14/2008. Information and follow up has been received from a physician concerning a 20 year old female who on 21-MAR-2008 was vaccinated intramuscularly "probably in the left arm" with her second dose of GARDASIL (lot# 0151X). On 24-MAR-2008 the patient called the doctor's office complaining of bruises and lump at the injection site and pain from her shoulder to armpit. The patient's bruises and lump at the injection site and pain from shoulder to armpit persisted. The patient did not experience any adverse effects after the first dose of GARDASIL. Additional information has been requested.
5:38 pm Attendee voiced complaints of blackness in front of his eyes", felt cold, Mom with him entire time, reported he had Anxiety with shots. 5:40 pm Attendee assisted to the cot to lie down, legs elevated;    5:46 pm Attendee observed becoming Floppy, sweating.  EMS called.   6:10 pm EMS cleared him and he departed, ambulating with mother, no voiced complaints- skin warm and dry.
This spontaneous report was received from a physician concerning an approximately 74 year old female patient with no pertinent medical history and no drug reactions or allergies. On 23-AUG-2013, the patient was vaccinated with 0.65 milliliter (ml) of ZOSTAVAX (lot number and expiry date reported as J002869 and 14-JUN-2014 respectively), subcutaneously. Concomitant therapies included citalopram and aspirin (reported as baby aspirin). On 24-AUG-2013, the patient developed a 10 X 11 centimeters (cm) erythema around her injection site after receiving ZOSTAVAX. The physician stated that the erythema had progressively gotten worse. The patient sought medical attention. The patient was at physician office at the time of reporting. No treatment was given. No lab tests were performed. The patient was not recovered from the adverse event. The relatedness for the adverse event was unknown for ZOSTAVAX. Additional information has been requested.
Pt developed varicella following gravidic exposure to natural varicella and subsequent vaccination with varicella virus vaccine live. She was vaccinated with the vaccine in 1994. In addition, she was pregnant at the time of exposure to natural varicella, vaccination and episode. It was noted that physical disorders have developed in the daughter the pt was carrying at the time of exposure.
Shakes, "tremors", fever 102, chest red (sick x 2 days off work).
Received flu shot 10/18/04 on left arm. On 10/20 or 10/21 arm started breaking out red bumps: spread on neck and chest and arm. Complained of arm and neck hurting. Slight fever.
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 29Aug2022 at 09:00 as dose 5 (booster), single (Lot number: Fp7140) at the age of 39 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Known allergy: Penicillin" (unspecified if ongoing); "Asthma" (unspecified if ongoing); "autoimmune disorder" (unspecified if ongoing); "hypothyroid" (unspecified if ongoing); "gerd" (unspecified if ongoing); "chronic pain" (unspecified if ongoing). Concomitant medication(s) included: PREDNISONE, start date: 08Oct2022, stop date: 15Oct2022. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "not recovered" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2022) Positive, notes: COVID 19 Treatment; (unspecified date) Negative, notes: After finishing Paxlovid symptoms seemed to improve for a few days, a d I testosterone negative for covid; (20Oct2022) Positive, notes: today I am again testing positive despite staying isolated. Therapeutic measures were taken as a result of drug ineffective, covid-19. After finishing Paxlovid symptoms seemed to improve for a few days, a d I testosterone negative for covid. Six days after finishing Paxlovid I started experiencing congestion and sneezing which worsened, and today I am again testing positive despite staying isolated.treatment start date 08Oct2022, and treatment end date.13Oct2022 of Paxlovid.
One hour after injection, felt his eyes swell and a tightening feeling in his throat.  He went to the Emergency Room and was treated and released.  They gave him oral Benadryl pills and observed him for approximately 2 hours.  He stated that he felt better.
A few hours after I received the shot I started to get a headache and pain in my chest. My neck started to feel stiff and I started to feel under the weather. After getting home I started to feel miserable and I took my temp and it was only 99 then it rose to 102 and I started to get severe muscle pains and the headache wasn't leaving. Felt like somebody was crushing my face. I had excruciating pain in my neck and arms and into my hands. I had fatigue and was light headed. I woke up the next morning and went to the Urgent Care.
May 12th received a tetanus shot. Immediately pain and swelling. Bad headache for 3 days then pain upon raising my arm. Pain radiates to the shoulder. Pain at nite when trying to sleep. Pain throughout the day, sometimes severe. Start physical therapy 7/19/17. Ache all over.
pain in the left arm/Having pain in left arm; when I lift my arm up it's like; my arm is just trembling all the time; pain in the back of her neck; Nerve is jerking, it's so jittery; When I try to make a muscle it's like annoying to me; This is a spontaneous report received from a contactable 68-year-old female patient reported for himself that she received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/lot number: EN6201, expiration date: 02May2021), via an unspecified route of administration on 05Mar2021 at single dose for covid-19 immunization. The patient's relevant medial history included she had a surgery on 13nov2019 to thyroid nodules taken out. Historical vaccine included bnt162b2 for covid-19 immunization on 25Jan2021 (1st Dose of Covid-19 vaccine Taken, LOT#: EN5318). Concomitant medications included levothyroxine sodium for thyroid disorder. On an unknown date, the patient had pain in the left arm/having pain in left arm; when i lift my arm up it's like and her arm was just trembling and all the time pain in the back of her neck, nerve was jerking, it was so jittery, when she tried to make a muscle it was like annoying to the patient. The patient took Tylenol 500 mg Twice daily for the events. The patient stopped taking Tylenol as it was not working and it was really giving her pains in my stomach, so the patient tried to switch to Advil or Aleve. The outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected
This spontaneous report as received from a nurse refers to a male patient of unknown age. No information on patient's medical history or concurrent conditions was provided. On 14-NOV-2014, the patient was vaccinated with the first dose of GARDASIL injection (dose, route of administration, lot# and expiration date were not provided). No information on patient's concomitant medication was provided. On 05-OCT-2015, the patient came into the office to receive his second dose of GARDASIL. No adverse effects were reported. Additional information has been requested.
Red, painful area surrounding injection site. Small, bumpy rash from elbow to injection site.
Event occurred during COVID vaccination clinic of students at School, under direction of Hospital COVID Vaccination team.  Syncopal event 5 minutes after injection.  Fell backwards striking her head on the floor.  Regained consciousness immediately.  Pale, diaphoretic, reported lightheadedness and nausea.  BP 86/50 HR 116 SpO2 99%.  Consumed several ounces water and ice pack to head and neck while in observation.  Released to parent after 30 minutes.  BP 110/60 HR 90 SpO2 98% skin dry, color pink, denied nausea.  Able to ambulate without assist.  Presented to urgent care 5/18/21 for concussion evaluation reporting sensitivity to bright  lights.  Advised by provider to  rest, avoid electronics and strenuous physical activity.
Patient reported bad stomach ache and not being able to eat for 3 months.  She mentioned Heartburn as well.  I asked if she saw a doctor and she said no,  she said that they could not see her until April 2023
I thought I had cold, a lot of mucus, sneezing, no fever. I called my doctor, to let him know I had tested positive for COVID-19 with a home test. He prescribed the PAXLOVID, I started to feel better in a couple days, but it took a couple of weeks to really feel like myself.
Patient received Pfizer vaccines 5/21/2021 and 6/11/2021. Mom brought adolescent to the clinic for a booster vaccine. But mom wanted Moderna for the booster instead of Pfizer. Adolescent was given 0.25mL of Moderna IM. Upon coding the visit, it was noted Moderna is not recommended for a booster dose for < 18 years of age. Patient monitored in clinic for 30 minutes after receiving vaccine. No complaints voiced. No distress or signs and symptoms of adverse reaction.
patient received flu shot on 09/16/23 reported to pharmacy on 09/18/23 warm red hard area several inches below where vaccine was given.  Patient contacting md to have evaluated.
Both hands tingled (similar to a numbing sensation) and felt swollen within 30 minutes, although there was no visible swelling.  Slight ache in both arms.   Finger joints became stiff by the next day. Developed ?Trigger Fingers? by the next day. Tingling Subsided, but stiff finger joints and ?Trigger Fingers? have not subsided.
Patient was administered the 0.25 mL booster dose of Moderna vaccine instead of 0.5 mL.